Clinical trial

Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma

NCT01284439

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-01-01

PhaseNA

Study timeline

Study start (unknown)2011-01-01Date precision: month

Registry last updated2011-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ocular Surface Diseaseunresolved

Glaucomaunresolved

Interventions

hydroxypropylmethylcelluloseDRUG

sodium hyaluronateDRUG · verified · RxNorm: sodium hyaluronate

Sponsors & collaborators

Mahidol Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01284439 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.